Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition
Y Leng, MH Liang, M Ren, Z Marinova… - Journal of …, 2008 - Soc Neuroscience
Lithium and valproic acid (VPA) are two primary drugs used to treat bipolar mood disorder
and have frequently been used in combination to treat bipolar patients resistant to …
and have frequently been used in combination to treat bipolar patients resistant to …
[HTML][HTML] Synergistic Neuroprotective Effects of Lithium and Valproic Acid or Other Histone Deacetylase Inhibitors in Neurons: Roles of Glycogen Synthase Kinase-3 …
Y Leng, MH Liang, M Ren, Z Marinova… - The Journal of …, 2008 - ncbi.nlm.nih.gov
Lithium and valproic acid (VPA) are two primary drugs used to treat bipolar mood disorder
and have frequently been used in combination to treat bipolar patients resistant to …
and have frequently been used in combination to treat bipolar patients resistant to …
Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition
Y Leng, MH Liang, M Ren… - The Journal of …, 2008 - pubmed.ncbi.nlm.nih.gov
Lithium and valproic acid (VPA) are two primary drugs used to treat bipolar mood disorder
and have frequently been used in combination to treat bipolar patients resistant to …
and have frequently been used in combination to treat bipolar patients resistant to …
[PDF][PDF] Synergistic Neuroprotective Effects of Lithium and Valproic Acid or Other Histone Deacetylase Inhibitors in Neurons: Roles of Glycogen Synthase Kinase-3 …
Y Leng, MH Liang, M Ren, Z Marinova… - The Journal of …, 2008 - Soc Neuroscience
Lithium and valproic acid (VPA) are two primary drugs used to treat bipolar mood disorder
and have frequently been used in combination to treat bipolar patients resistant to …
and have frequently been used in combination to treat bipolar patients resistant to …
Synergistic Neuroprotective Effects of Lithium and Valproic Acid or Other Histone Deacetylase Inhibitors in Neurons: Roles of Glycogen Synthase Kinase-3 Inhibition
Y Leng, MH Liang, M Ren, Z Marinova… - The Journal of …, 2008 - cir.nii.ac.jp
抄録< jats: p> Lithium and valproic acid (VPA) are two primary drugs used to treat bipolar
mood disorder and have frequently been used in combination to treat bipolar patients …
mood disorder and have frequently been used in combination to treat bipolar patients …
Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
Y Leng, MH Liang, M Ren, Z Marinova… - The Journal of …, 2008 - europepmc.org
Lithium and valproic acid (VPA) are two primary drugs used to treat bipolar mood disorder
and have frequently been used in combination to treat bipolar patients resistant to …
and have frequently been used in combination to treat bipolar patients resistant to …
[HTML][HTML] Synergistic Neuroprotective Effects of Lithium and Valproic Acid or Other Histone Deacetylase Inhibitors in Neurons: Roles of Glycogen Synthase Kinase-3 …
Y Leng, MH Liang, M Ren, Z Marinova… - The Journal of …, 2008 - ncbi.nlm.nih.gov
Lithium and valproic acid (VPA) are two primary drugs used to treat bipolar mood disorder
and have frequently been used in combination to treat bipolar patients resistant to …
and have frequently been used in combination to treat bipolar patients resistant to …
Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
Y Leng, MH Liang, M Ren, Z Marinova… - The Journal of …, 2008 - europepmc.org
Lithium and valproic acid (VPA) are two primary drugs used to treat bipolar mood disorder
and have frequently been used in combination to treat bipolar patients resistant to …
and have frequently been used in combination to treat bipolar patients resistant to …